ARTICLE | Company News
GlaxoSmithKline other research news
June 18, 2001 7:00 AM UTC
GSK and colleagues published in Nature the structural basis for the ability of PXR, a regulator of the main drug-metabolizing enzyme CYP3A, to bind a variety of xenobiotics (exogenous chemicals). The...